Loading data for DMIIR — first visit, this takes a few seconds.
Drugs Made In America Acquisition II Cor... (DMIIR)
NasdaqGM: DMIIR
· 实时价格 · USD
0.08
-0.01 (-11.11%)
收盘价： Sep 01, 2026, 2:03 PM
股价、关键数字和最新消息，都在这一页。
Drugs Made In America Acquisition II Corp.（DMIIR）股价、分析与数据
暂无数据
| 买价 | 0.07 |
| 市值 | n/a |
| 营收（TTM） | n/a |
| 净利润（TTM） | 13M |
| 0.00 | |
| n/a | |
| n/a | |
| n/a | |
| 市净率（TTM） | -0.28 |
| 市销率（TTM） | 0.00 |
| 财报日期 | n/a |
| 卖价 | 0.1 |
| 成交量 | 40,475 |
| 20日均量 | n/a |
| 开盘价 | 0.08 |
| 前收盘价 | 0.09 |
| 日内区间 | 0.08 - 0.08 |
| 52周区间 | 0.08 - 0.08 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 DMIIR
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York...
公司完整简介财务表现
undefined年，Drugs Made In America Acquisition II的营收为n/a，较上一年的n/a增长undefined%。 净利润为n/a，增长undefined%。
财务报表财报意外
Drugs Made In America Acquisition II 已于 Invalid Date 发布季度财报：
- 营收为 n/a 低于预期 $0, ， NaN% 同比增长.
- 每股收益为 低于预期 , ， NaN% 同比增长.
